Literature DB >> 22343584

Repetitive transcranial magnetic stimulation safely administered after seizure.

Dhruv Bagati, Sunil Mittal, Samir Kumar Praharaj, Manish Sarcar, Minal Kakra, Pankaj Kumar.   

Abstract

High-frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex has been clearly reported to be effective in the treatment of depression. We report a patient with treatment-resistant depression, without any known risk factors, who developed seizure during the fourth rTMS session. After written informed consent, he received further rTMS sessions under cover of antiepileptic drug valproate and improved without recurrence of seizure.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22343584     DOI： 10.1097/YCT.0b013e318221f9b1

Source DB:  PubMed          Journal:  J ECT        ISSN： 1095-0680            Impact factor:   3.635


  3 in total

Review 1.  Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion.

Authors:  Christine E Dobek; Daniel M Blumberger; Jonathan Downar; Zafiris J Daskalakis; Fidel Vila-Rodriguez
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-30       Impact factor: 2.570

Review 2.  Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review.

Authors:  Debra J Stultz; Savanna Osburn; Tyler Burns; Sylvia Pawlowska-Wajswol; Robin Walton
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-07       Impact factor: 2.570

Review 3.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.